Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Chromosome 22 Open Reading Frame 9 (C22orf9) (Middle Region) Peptid

C22orf9 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974207
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Chromosome 22 Open Reading Frame 9 (C22orf9) (Middle Region) Peptid (ABIN974207)

Target

C22orf9 (Chromosome 22 Open Reading Frame 9 (C22orf9))

Spezies

Human

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-C22orf9 antibody (Catalog #: ARP55213_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    C22orf9 (Chromosome 22 Open Reading Frame 9 (C22orf9))

    Hintergrund

    The function of C22orf9 remains unknown.

    Alias Symbols: C22orf9

    Protein Interaction Partner: YWHAB,YWHAG,YWHAZ,USP11,YWHAG,YWHAQ,YWHAZ

    Protein Size: 409

    Molekulargewicht

    46 kDa

    Gen-ID

    23313

    NCBI Accession

    NM_015264, NP_056079

    UniProt

    Q6ICG6
Sie sind hier:
Chat with us!